Applications of Nanopore sequencing in precision cancer medicine
International Journal of Cancer · 15.12.2024 · 155 (12) · 2129-2140
DOI: 10.1002/ijc.35100 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Cancer, online erschienen am 19.07.2024. Verfasst von Sergey A Dyshlovoy und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Oxford Molecular Diagnostics Centre, University of Oxford, Level 4, John Radcliffe Hospital, Oxford, UK. Hauptthemen laut MEDLINE: Precision Medicine, Neoplasms, Nanopore Sequencing. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Oxford Nanopore Technologies sequencing, also referred to as Nanopore sequencing, stands at the forefront of a revolution in clinical genetics, offering the potential for rapid, long read, and real‐time DNA and RNA sequencing. This technology is currently making sequencing more accessible and affordable. In this comprehensive review, we explore its potential regarding precision cancer diagnostics and treatment. We encompass a critical analysis of clinical cases where Nanopore sequencing was successfully applied to identify point mutations, splice variants, gene fusions, epigenetic modifications, non‐coding RNAs, and other pivotal biomarkers that defined subsequent treatment strategies. Additionally, we address the challenges of clinical applications of Nanopore sequencing and discuss the current efforts to overcome them.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Oxford Molecular Diagnostics Centre, University of Oxford, Level 4, John Radcliffe Hospital, Oxford, UK.
- Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.
- Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.
- Institute for Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
ORCID-Profile: Sergey A Dyshlovoy, Stefanie Paigin, Ann-Kristin Afflerbach, Annabelle Lobermeyer, Stefan Werner, Ulrich Schüller, Lina Bergmann, Simon A Joosse
Zitieren
APA
Dyshlovoy, S. A., Paigin, S., Afflerbach, A. K., Lobermeyer, A., Werner, S., Schüller, U., Bokemeyer, C., Schuh, A. H., Bergmann, L., von Amsberg, G., & Joosse, S. A. (2024). Applications of Nanopore sequencing in precision cancer medicine. International Journal of Cancer, 155(12), 2129-2140. https://doi.org/10.1002/ijc.35100
Vancouver
Dyshlovoy SA, Paigin S, Afflerbach AK, Lobermeyer A, Werner S, Schüller U, et al. Applications of Nanopore sequencing in precision cancer medicine. International Journal of Cancer. 2024;155(12):2129-2140. doi:10.1002/ijc.35100
BibTeX
@article{Dyshlovoy2024,
author = {Dyshlovoy, Sergey A and Paigin, Stefanie and Afflerbach, Ann-Kristin and Lobermeyer, Annabelle and Werner, Stefan and Schüller, Ulrich and Bokemeyer, Carsten and Schuh, Anna H and Bergmann, Lina and von Amsberg, Gunhild and Joosse, Simon A},
title = {Applications of Nanopore sequencing in precision cancer medicine},
journal = {International Journal of Cancer},
year = {2024},
volume = {155},
number = {12},
pages = {2129--2140},
doi = {10.1002/ijc.35100}
}
EUVIMED